Company
AIRS Medical
Seoul, South Korea AI-MRI company founded in 2018; its software now runs in more than 6 million MRI exams a year at 1,700-plus institutions, with SwiftSight Body Composition its newest FDA clearance.
2 stories
Regulatory News has published 2 stories about AIRS Medical between 6 October 2026 and 7 October 2026, each sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 7 October 2026.
This page is generated from Regulatory News’ editorial coverage of AIRS Medical. It is not an advertisement.
On the record
- Company
- AIRS Medical Inc.
- Headquarters
- Seoul, South Korea
- Founded
- October 2018, by a team from Seoul National University including CEO Hyeseong Lee, M.D.
- Regulator
- U.S. Food and Drug Administration (CDRH)
- Latest milestone
- FDA 510(k) clearance, SwiftSight Body Composition
Each line is taken from the most recent story of ours that states it.
